Cultivate

Cultivate(MD) is a venture capital fund established in 2017 and located in Grand Rapids, Michigan. The fund specializes in supporting early-stage healthcare companies, with a particular focus on medical device and orthopedic technologies. By targeting innovative ventures in these sectors, Cultivate(MD) aims to foster advancements that can improve patient care and outcomes in the healthcare industry.

16 past transactions

Prana Thoracic

Venture Round in 2024
Prana Thoracic, Inc., based in Houston, is a medical device startup focused on developing innovative solutions for the early intervention of lung cancer, the leading cause of cancer-related deaths in the United States. The company aims to address the critical challenges in lung cancer screening and diagnosis, where only a small percentage of cases are detected at an early stage. Prana Thoracic's advanced electrosurgical instrument utilizes bipolar radiofrequency energy to perform minimally invasive procedures, enabling physicians to capture and diagnose small, hard-to-reach lung nodules while reducing the risk of complications. By enhancing the tools available for surgical oncology in lung cancer, Prana Thoracic seeks to improve patient outcomes and capitalize on recent advancements in screening guidelines, ensuring early intervention opportunities are not missed.

Nanochon

Seed Round in 2024
Nanochon is a medical device company focused on developing innovative solutions for treating cartilage damage in joints. Utilizing 3D printing technology and proprietary nanomaterials, the company aims to create implantable devices that replace lost or damaged cartilage and stimulate new tissue growth. This approach enables healthcare providers to offer cost-effective, on-demand treatments tailored to young and active patients suffering from knee injuries or diseases.

Nanochon

Venture Round in 2023
Nanochon is a medical device company focused on developing innovative solutions for treating cartilage damage in joints. Utilizing 3D printing technology and proprietary nanomaterials, the company aims to create implantable devices that replace lost or damaged cartilage and stimulate new tissue growth. This approach enables healthcare providers to offer cost-effective, on-demand treatments tailored to young and active patients suffering from knee injuries or diseases.

Virtual Incision

Series C in 2023
Virtual Incision is a medical technology company focused on developing innovative robotic-assisted surgical devices, specifically targeting colon resection. The company has created the MIRA (Miniaturized In vivo Robotic Assistant) Platform, which is a pioneering miniaturized surgical robotic support device. This platform allows for efficient operating room setups in minutes, eliminating the need for cumbersome equipment handling such as draping or docking. By enhancing the surgical process, Virtual Incision aims to improve clinical outcomes while also addressing healthcare costs, positioning itself as a leader in the field of robotic-assisted surgery.

SentiAR

Series B in 2023
SentiAR, Inc. is a digital health company based in St. Louis, Missouri, focused on developing a 3D augmented reality holographic platform aimed at enhancing interventional medical procedures. Incorporated in 2017 and originating from Washington University, SentiAR's technology allows for real-time holographic visualization of a patient's anatomy and catheter positioning during procedures, utilizing data from various imaging modalities such as CT and MRI. This innovative platform is designed to create an interactive and controllable interface for clinicians, thereby improving the accuracy and safety of cardiac arrhythmia treatments. SentiAR's mission is to significantly enhance the experience for both patients and healthcare providers in catheter lab environments. The company is currently working towards obtaining FDA approval for its platform.

Shoulder Innovations

Series D in 2023
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.

SpinTech MRI

Series A in 2022
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.

Strados Labs

Seed Round in 2021
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

Deepstash

Seed Round in 2020
Deepstash is a knowledge-based platform that curates and organizes bite-sized ideas from a variety of online sources, including articles, videos, and podcasts. Aimed at addressing the overwhelming amount of information available on the Internet, Deepstash allows users to extract and save insights that resonate with them, facilitating personal growth and productivity. Users can easily organize their saved ideas and share them with a community that values the discovery of meaningful content. The platform encourages individuals to distill their learnings into what they refer to as "stashing," ultimately promoting a more focused and enriching engagement with the information they consume. The Deepstash app is accessible on multiple platforms, including mobile devices and the web.

Embody

Series A in 2020
Embody, Inc., established in 2014 and based in Norfolk, Virginia, is a regenerative medicine company specializing in the development and commercialization of implantable medical devices. The company focuses on addressing unmet demands in soft tissue restoration and regeneration, with a particular emphasis on tendon and ligament repair. Embody's innovative collagen-based microfiber implants are designed to replicate the biological and biomechanical properties of native tissue, aiming to restore pre-injury performance for a wide range of patients, including warfighters, athletes, and those suffering from sports injuries. The company's technology, which includes microfluidic biofabrication and electrospinning, enables it to create advanced biomaterial-based devices that enhance healthcare providers' ability to repair and regenerate damaged soft tissue.

Genesis Software Innovations

Seed Round in 2019
Genesis Software Innovations develops innovative and integrated software tools focused around surgical centers in the orthopedic space. The company's vision is to create great software tools that give medical professionals the information they need to produce repeatedly excellent, surgical results.

Magnesium Development

Series A in 2019
Magnesium Development Company, LLC is a medical device development firm based in Grand Rapids, Michigan, founded in 2014. The company specializes in innovative medical devices utilizing a breakthrough magnesium alloy technology known as BioMg 250. This technology merges the desirable handling and strength characteristics of metal with the advantage of complete bioabsorption, addressing significant challenges in sports medicine orthopedics. Magnesium Development's products are designed to improve surgical outcomes for soft tissue injuries, such as those affecting the knee, shoulder, and lower extremities. By providing a resorbable solution, the company aims to mitigate issues like delayed resorption, mechanical failure, and complications related to traditional materials, ultimately supporting patients in their recovery and return to active lifestyles.

SpinTech MRI

Venture Round in 2018
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.

Medical Ingenuities

Venture Round in 2018
Medical Ingenuities, LLC is a medical device company based in Wheaton, Illinois, specializing in innovative solutions to enhance patient care and improve healthcare systems. The company has developed the PH Band, a radial artery occlusion device designed to prevent complications following trans-radial procedures. This device provides real-time feedback to medical personnel, allowing them to monitor the patency of the radial artery and confirm successful hemostasis. By offering Doppler feedback that audibly detects antegrade flow beyond the compression point, the PH Band enables healthcare professionals to streamline their workflow and reduce the risk of occlusion-related issues.

Shoulder Innovations

Series A in 2018
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.

Shoulder Innovations

Series A in 2017
Shoulder Innovations, Inc. is a medical device company based in Holland, Michigan, specializing in orthopedic solutions for shoulder replacement surgery. Founded in 2009, the company has developed an advanced Total Shoulder Replacement System that features innovative inset glenoid fixation technology, addressing the critical issue of glenoid implant stability during shoulder arthroplasty. This technology not only enhances the robustness of the glenoid platform but also simplifies the surgical instrumentation, aiming to reduce operative time and costs. The company's products are marketed through distribution partners in the United States and are designed to improve patient outcomes by minimizing the risk of glenoid loosening, which is a leading cause of revision surgeries. By focusing on reliable fixation and simplified surgical techniques, Shoulder Innovations strives to enhance the efficacy and longevity of shoulder implants while potentially lowering overall healthcare costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.